Repression of linc01555 up-regulates angiomotin-p130 via the microRNA-122-5p/clic1 axis to impact vasculogenic mimicry-mediated chemotherapy resistance in small cell lung cancer

References

• Chen Y, Shen T, Ding X, et al. lncRNA MRUL suppressed non-small cell lung cancer cells proliferation and invasion by targeting miR-17-5p/srsf2 axis. Biomed Res Int. 2020;2020:9567846.
   PubMed Web of Science ®Google Scholar
• Sun Y, Hu B, Wang Q, et al. Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a. Cell Death Amp Dis. 2018 Jan 24;9(2):85. DOI:10.1038/s41419-017-0113-5
   PubMedGoogle Scholar
• Sun Y, Zhou Y, Bai Y, et al. A long non-coding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients. Mol Cancer. 2017 Oct 17;16(1):162. DOI:10.1186/s12943-017-0729-1
   PubMedGoogle Scholar
• Gomes AQ, Nolasco S, Soares H. Non-Coding RNAs: multi-tasking molecules in the cell. Int J Mol Sci. 2013 Jul 31;14(8):16010–16039. DOI:10.3390/ijms140816010
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhang Y, Du L, et al. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer. Mol Oncol. 2018 May;12(5):648–658. DOI:10.1002/1878-0261.12188
   PubMed Web of Science ®Google Scholar
• Niu Y, Ma F, Huang W, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Mol Cancer. 2017 Jan 9;16(1):5. DOI:10.1186/s12943-016-0575-6
   PubMedGoogle Scholar
• Zhao X, Zhao Z Linc01555 promotes proliferation, migration and invasion of gastric carcinoma cells by interacting with Notch signaling pathway. J Buon. 2020 Mar-Apr;25(2):1007–1012.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen X, Zhou H, et al. The long noncoding RNA, LINC01555, promotes invasion and metastasis of colorectal cancer by activating the neuropeptide, Neuromedin U. Med Sci Monit. 2019 May 30;25:4014–4024. DOI:10.12659/MSM.916508
   PubMed Web of Science ®Google Scholar
• Liu WZ, Liang FH, Yang GY, et al. LncRNA LINC01116 sponges miR-93-5p to promote cell invasion and migration in small cell lung cancer. BMC Pulm Med. 2021;21(1):50. DOI:10.1186/s12890-020-01369-3
   PubMed Web of Science ®Google Scholar
• Li X, Lv F, Li F, et al. Long noncoding RNA H19 facilitates small cell lung cancer tumorigenesis through miR-140-5p/fgf9 axis. Onco Targets Ther. 2020;13:3525–3534.
   PubMed Web of Science ®Google Scholar
• Huang W, Yang Y, Wu J, et al. Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-β signalling. Cell Death Differ. 2020 May;27(5):1709–1727. DOI:10.1038/s41418-019-0455-x
   PubMed Web of Science ®Google Scholar
• Jia Y, Zhao J, Yang J, et al. miR-301 regulates the SIRT1/SOX2 pathway via CPEB1 in the breast cancer progression. Mol Ther Oncolytics. 2021 Sep 24;22:13–26. DOI:10.1016/j.omto.2021.03.007
   PubMed Web of Science ®Google Scholar
• Yu S, Ruan X, Liu X, et al. HNRNPD interacts with ZHX2 regulating the vasculogenic mimicry formation of glioma cells via linc00707/mir-651-3p/sp2 axis. Cell Death Amp Dis. 2021 Feb 4;12(2):153. DOI:10.1038/s41419-021-03432-1
   PubMed Web of Science ®Google Scholar
• Long B, Li N, Xu X, et al. Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1. Biochem Biophys Res Commun. 2018;505:561–568. DOI:10.1016/j.bbrc.2018.09.160
   PubMed Web of Science ®Google Scholar
• Yuan JB, Gu L, Chen L, et al. Annexin A8 regulated by lncRNA-TUG1/miR-140-3p axis promotes bladder cancer progression and metastasis. Mol Ther Oncolytics. 2021 Sep 24;22:36–51. DOI:10.1016/j.omto.2021.04.008
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang T, Xia L, et al. LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/sdc4 axis. Cancer Cell Int. 2021 May 29;21(1):284. DOI:10.1186/s12935-021-01993-x
   PubMed Web of Science ®Google Scholar
• Shen Q, Xu Z, Xu S Long noncoding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR514a3p/ulk1 axis in human nonsmall cell lung cancer. Int J Oncol. 2020 Oct;57(4):967–979.
   PubMed Web of Science ®Google Scholar
• He C, Liu YY, Li JH, et al. LncRNA RPSAP52 promotes cell proliferation and inhibits cell apoptosis via modulating miR-665/STAT3 in gastric cancer. Bioengineered. 2022;13:8699–8711. DOI:10.1080/21655979.2022.2054754
   PubMed Web of Science ®Google Scholar
• Zhang WT, Wang ZF, Cai GH, et al. Circ_dock1 regulates USP11 through miR-132-3p to control colorectal cancer progression. World J Surg Oncol. 2021;19:67.
   PubMed Web of Science ®Google Scholar
• Huang N, Guo W, Ren K, et al. LncRNA AFAP1-AS1 supresses miR-139-5p and promotes cell proliferation and chemotherapy resistance of non-small cell lung cancer by competitively upregulating RRM2. Front Oncol. 2019;9:1103.
   PubMed Web of Science ®Google Scholar
• Wang D, Zheng J, Liu X, et al. Knockdown of USF1 inhibits the vasculogenic mimicry of glioma cells via stimulating SNHG16/miR-212-3p and linc00667/mir-429 axis. Mol Ther Nucl Acids. 2019 Mar 1;14:465–482. DOI:10.1016/j.omtn.2018.12.017
   Google Scholar
• Li D, Shen Y, Ren H, et al. Angiomotin-P130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway. J Bioenerg Biomembr. 2021 Jun;53(3):295–305. DOI:10.1007/s10863-021-09891-7
   PubMed Web of Science ®Google Scholar
• Mao Y, Xue P, Li L, et al. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRnagene pairs in smallcell lung cancer. Mol Med Rep. 2019 Sep;20(3):2199–2208. DOI:10.3892/mmr.2019.10441
   PubMed Web of Science ®Google Scholar
• Chen P, Guo H, Liu Y, et al. Aberrant methylation modifications reflect specific drug responses in small cell lung cancer. Genomics. 2021 May;113(3):1114–1126. DOI:10.1016/j.ygeno.2020.12.045
   PubMed Web of Science ®Google Scholar
• Zeng F, Wang Q, Wang S, et al. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression. Oncogene. 2020 Jan;39(2):293–307. DOI:10.1038/s41388-019-0984-2
   PubMed Web of Science ®Google Scholar
• Jin Y, Wong YS, Goh BKP, et al. Circulating microRnas as potential diagnostic and prognostic biomarkers in hepatocellular carcinoma. Sci Rep. 2019 Jul 18;9(1):10464. DOI:10.1038/s41598-019-46872-8
   PubMedGoogle Scholar
• Li M, Zou X, Xia T, et al. A five-miRNA panel in plasma was identified for breast cancer diagnosis. Cancer Med. 2019 Nov;8(16):7006–7017. DOI:10.1002/cam4.2572
   PubMed Web of Science ®Google Scholar
• Yuan Q, Yu H, Chen J, et al. ADAM10 promotes cell growth, migration, and invasion in osteosarcoma via regulating E-cadherin/β-catenin signaling pathway and is regulated by miR-122-5p. Cancer Cell Int. 2020;20:99.
   PubMed Web of Science ®Google Scholar
• Liu YH, Liu JL, Wang Z, et al. MiR-122-5p suppresses cell proliferation, migration and invasion by targeting SATB1 in nasopharyngeal carcinoma. Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):622–629. DOI:10.26355/eurrev_201901_16876
   PubMed Web of Science ®Google Scholar
• Dai C, Zhang Y, Xu Z, et al. MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma. Cancer Cell Int. 2020;20:98.
   PubMed Web of Science ®Google Scholar
• Hu N, Tian Y, Song Y, et al. miR1225p suppresses the oncogenesis of PTC by inhibiting DUSP4 expression. Mol Med Rep. 2021 May;23(5). DOI:10.3892/mmr.2021.12007
   Web of Science ®Google Scholar
• Li X, Ma C, Luo H, et al. Identification of the differential expression of genes and upstream microRnas in small cell lung cancer compared with normal lung based on bioinformatics analysis. Medicine (Baltimore). 2020 Mar;99(11):e19086. DOI:10.1097/MD.0000000000019086
   PubMed Web of Science ®Google Scholar
• Wei T, Zhu W, Fang S, et al. miR-495 promotes the chemoresistance of SCLC through the epithelial-mesenchymal transition via Etk/BMX. Am J Cancer Res. 2017;7(3):628–646.
   PubMed Web of Science ®Google Scholar
• Li BP, Mao YT, Wang Z, et al. CLIC1 promotes the progression of gastric cancer by regulating the MAPK/AKT pathways. Cell Physiol Biochem. 2018;46(3):907–924. DOI:10.1159/000488822
   PubMedGoogle Scholar
• Wechman SL, Emdad L, Sarkar D, et al. Vascular mimicry: triggers, molecular interactions and in vivo models. Adv Cancer Res. 2020;148:27–67.
   PubMed Web of Science ®Google Scholar
• Zhao J, Wu J, Qin Y, et al. LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3/Slug axis and epithelial-to-mesenchymal transition in gastric cancer. Cell Oncol (Dordr). 2020 Oct;43(5):863–876. DOI:10.1007/s13402-020-00532-6
   PubMed Web of Science ®Google Scholar
• Troyanovsky B, Levchenko T, Månsson G, et al. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol. 2001 Mar 19;152(6):1247–1254. DOI:10.1083/jcb.152.6.1247
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang X, Chen Z, et al. Angiomotin-P130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer. Cell Death Amp Dis. 2019 Feb 21;10(3):179. DOI:10.1038/s41419-019-1427-2
   PubMedGoogle Scholar